Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Lower P1NP serum levels: A predictive marker of bone loss after 1 year follow-up in premenopausal systemic lupus erythematosus patients (2015)

  • Authors:
  • USP affiliated authors: BONFA, ELOISA SILVA DUTRA DE OLIVEIRA - FM ; PEREIRA, ROSA MARIA RODRIGUES - FM
  • USP Schools: FM; FM
  • DOI: 10.1007/s00198-014-2860-9
  • Subjects: OSTEOGÊNESE; LÚPUS ERITEMATOSO SISTÊMICO; BIOMARCADORES; MENOPAUSA
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s00198-014-2860-9 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed

    Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FM2682017-10BCSEP 116 2015
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SEGURO, L. P. C.; CASELLA, C. B.; CAPARBO, V. F.; et al. Lower P1NP serum levels: A predictive marker of bone loss after 1 year follow-up in premenopausal systemic lupus erythematosus patients. Osteoporosis international, London, v. 26, p. 459-467, 2015. Disponível em: < doi: 10.1007/s00198-014-2860-9 > DOI: 10.1007/s00198-014-2860-9.
    • APA

      Seguro, L. P. C., Casella, C. B., Caparbo, V. F., Oliveira, R. M., Bonfa, A., & Pereira, R. M. R. (2015). Lower P1NP serum levels: A predictive marker of bone loss after 1 year follow-up in premenopausal systemic lupus erythematosus patients. Osteoporosis international, 26, 459-467. doi:10.1007/s00198-014-2860-9
    • NLM

      Seguro LPC, Casella CB, Caparbo VF, Oliveira RM, Bonfa A, Pereira RMR. Lower P1NP serum levels: A predictive marker of bone loss after 1 year follow-up in premenopausal systemic lupus erythematosus patients [Internet]. Osteoporosis international. 2015 ; 26 459-467.Available from: doi: 10.1007/s00198-014-2860-9
    • Vancouver

      Seguro LPC, Casella CB, Caparbo VF, Oliveira RM, Bonfa A, Pereira RMR. Lower P1NP serum levels: A predictive marker of bone loss after 1 year follow-up in premenopausal systemic lupus erythematosus patients [Internet]. Osteoporosis international. 2015 ; 26 459-467.Available from: doi: 10.1007/s00198-014-2860-9

    Referências citadas na obra
    Pereira RM, Carvalho JF, Canalis E (2010) Glucocorticoid-induced osteoporosis in rheumatic diseases. Clinics (Sao Paulo) 65:1197–1205
    Casella CB, Seguro LP, Takayama L, Medeiros D, Bonfa E, Pereira RM (2012) Juvenile onset systemic lupus erythematosus: a possible role for vitamin D in disease status and bone health. Lupus 21:1335–1342
    Lane NE (2006) Therapy insight: osteoporosis and osteonecrosis in systemic lupus erythematosus. Nat Clin Pract Rheumatol 2:562–569
    Bhalla AK (2010) Management of osteoporosis in a pre-menopausal woman. Best Pract Res Clin Rheumatol 24:313–327
    Pereira RM, Carvalho JF, Paula AP, Zerbini C, Domiciano DS, Gonçalves H et al (2012) Committee for Osteoporosis and Bone Metabolic Disorders of the Brazilian Society of Rheumatology; Brazilian Medical Association; Brazilian Association of Physical Medicine and Rehabilitation. Guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis. Rev Bras Reumatol 52:580–593
    Grossman JM, Gordon R, Ranganath VK, Deal C, Caplan L, Chen W et al (2010) American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (hoboken) 62:1515–1526
    Lekamwasam S, Adachi JD, Agnusdei D, Bilezikian J, Boonen S, Borgström F et al (2012) Joint IOF-ECTS GIO Guidelines Working Group. A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int 23:2257–2276
    Franchimont N, Canalis E (2003) Management of glucocorticoid-induced osteoporosis in premenopausal women with autoimmune disease. Autoimmun Rev 2:224–228
    Levy S, Fayez I, Taguchi N, Han JY, Aiello J, Matsui D et al (2009) Joint IOF-ECTS GIO Guidelines Working Group. Pregnancy outcome following in utero exposure to bisphosphonates. Bone 44:428–430
    Kalla AA, Fataar AB, Jessop SJ, Bewerunge L (1993) Loss of trabecular bone mineral density in systemic lupus erythematosus. Arthritis Rheum 36:1726–1734
    Regio P, Bonfá E, Takayama L, Pereira R (2008) The influence of lean mass in trabecular and cortical bone in juvenile onset systemic lupus erythematosus. Lupus 17:787–792
    Sinigaglia L, Varenna M, Binelli L, Zucchi F, Ghiringhella D, Gallazzi M et al (1999) Determinants of bone mass in systemic lupus erythematosus: a cross-sectional study on premenopausal women. J Rheumatol 26:1280–1284
    Yeap SS, Fauzi AR, Kong NC, Halim AG, Soehardy Z, Rahimah S et al (2009) Influences on bone mineral density in Malaysian premenopausal systemic lupus erythematosus patients on corticosteroids. Lupus 18:178–181
    Souto MI, Coelho A, Guo C, Mendonça LM, Pinheiro MF, Papi JÁ et al (2012) The prevalence of low bone mineral density in Brazilian patients with systemic lupus erythematosus and its relationship with the disease damage index and other associated factors. J Clin Densitom 15:320–327
    Pons F, Peris P, Guañabens N, Font J, Huguet M, Espinosa G et al (1995) The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in pre-menopausal women. Br J Rheumatol 34:742–746
    Hansen M, Halberg P, Kollerup G, Pedersen-Zbinden B, Hørslev-Petersen K, Hyldstrup L et al (1998) Bone metabolism in patients with systemic lupus erythematosus. Effect of disease activity and glucocorticoid treatment. Scand J Rheumatol 27:197–206
    Formiga F, Nolla JM, Moga I, Roig-Escofet D (1996) Sequential study of bone mineral density in patients with systemic lupus erythematosus. Ann Rheum Dis 55:857
    Kipen Y, Briganti EM, Strauss B, Will R, Littlejohn G, Morand E (1999) Three year follow-up of bone mineral density change in premenopausal women with systemic lupus erythematosus. J Rheumatol 26:310–317
    Jardinet D, Lefebvre C, Depresseux G, Lambert M, Devogelaer JP, Houssiau FA (2000) Longitudinal analysis of bone mineral density in pre-menopausal female systemic lupus erythematosus patients: deleterious role of glucocorticoid therapy at the lumbar spine. Rheumatology (Oxford) 39:389–392
    Boyanov M, Robeva R, Popivanov P (2003) Bone mineral density changes in women with systemic lupus erythematosus. Clin Rheumatol 22:318–323
    Uaratanawong S, Deesomchok U, Hiransuttikul N, Uaratanawong S (2004) Four years follow-up of bone mineral density change in premenopausal women with systemic lupus erythematosus. J Med Assoc Thai 87:1374–1379
    Jacobs J, Korswagen LA, Schilder AM, van Tuyl LH, Dijkmans BA, Lems WF et al (2013) Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus. Osteoporos Int 24:1827–1833
    Baim S, Wilson CR, Lewiecki EM, Luckey MM, Downs RW Jr, Lentle BC (2005) Precision assessment and radiation safety for dual-energy X-ray absorptiometry: position paper of the International Society for Clinical Densitometry. J Clin Densitom 8:371–378
    Vasikaran S, Eastell R, Bruyère O, Foldes AJ, Garnero P, Griesmacher A et al (2011) IOF-IFCC Bone Marker Standards Working Group. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 22:391–420
    Brown JP, Albert C, Nassar BA, Adachi JD, Cole D, Davison KS et al (2009) Bone turnover markers in the management of postmenopausal osteoporosis. Clin Biochem 42:929–942
    Redlich K, Ziegler S, Kiener HP, Spitzauer S, Stohlawetz P, Bernecker P et al (2000) Bone mineral density and biochemical parameters of bone metabolism in female patients with systemic lupus erythematosus. Ann Rheum Dis 59:308–310
    Teichmann J, Lange U, Stracke H, Federlin K, Bretzel RG (1999) Bone metabolism and bone mineral density of systemic lupus erythematosus at the time of diagnosis. Rheumatol Int 18:137–140
    Borba VZ, Vieira JG, Kasamatsu T, Radominski SC, Sato EI, Lazaretti-Castro M (2009) Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporos Int 20:427–433
    Becker A, Fischer R, Scherbaum WA, Schneider M (2001) Osteoporosis screening in systemic lupus erythematosus: impact of disease duration and organ damage. Lupus 10:809–814
    Boyce BF, Xing L (2007) Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther 9:Suppl 1–S1
    Carmona-Fernandes D, Santos MJ, Perpétuo IP, Fonseca JE, Canhão H (2011) Soluble receptor activator of nuclear factor κB ligand/osteoprotegerin ratio is increased in systemic lupus erythematosus patients. Arthritis Res Ther 13:R175
    Long L, Liu Y, Wang S, Zhao Y, Guo J, Yu P et al (2010) Dickkopf-1 as potential biomarker to evaluate bone erosion in systemic lupus erythematosus. J Clin Immunol 30:669–675
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277
    Fuchs SC, Guimarães SM, Sortica C, Wainberg F, Dias KO, Ughini M et al (2002) Reliability of race assessment based on the race of the ascendants: a cross-sectional study. BMC Public Health 2:1–5
    Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640
    Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M et al (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363–369
    Lewiecki EM, Gordon CM, Baim S, Leonard MB, Bishop NJ, Bianchi ML et al (2008) International Society for Clinical Densitometry 2007 adult and pediatric official positions. Bone 43:1115–1121
    El Maghraoui A, Achemlal L, Bezza A (2006) Monitoring of dual-energy X-ray absorptiometry measurement in clinical practice. J Clin Densitom 9:281–286
    Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148
    Domiciano DS, Figueiredo CP, Lopes JB, Kuroishi ME, Takayama L, Caparbo VF et al (2013) Vertebral fracture assessment by dual X-ray absorptiometry: a valid tool to detect vertebral fractures in community-dwelling older adults in a population-based survey. Arthritis Care Res (Hoboken) 65:809–815
    Compston J (2010) Management of glucocorticoid-induced osteoporosis. Nat Rev Rheumatol 6:82–88
    Gifre L, Ruiz-Gaspà S, Monegal A, Nomdedeu B, Filella X, Guañabens N et al (2013) Effect of glucocorticoid treatment on Wnt signalling antagonists (sclerostin and Dkk-1) and their relationship with bone turnover. Bone 57:272–276
    Conti A, Sartorio A, Ferrero S, Ferrario S, Ambrosi B (1996) Modifications of biochemical markers of bone and collagen turnover during corticosteroid therapy. J Endocrinol Invest 19:127–130
    Haskelberg H, Hoy JF, Amin J, Ebeling PR, Emery S, Carr A et al (2012) Changes in bone turnover and bone loss in HIV-infected patients changing treatment to tenofovir-emtricitabine or abacavir-lamivudine. PLoS One 7:e38377
    Parfitt AM (1994) Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone. J Cell Biochem 55:273–286
    Yamamoto T, Tsujimoto M, Hamaya E, Sowa H (2013) Assessing the effect of baseline status of serum bone turnover markers and vitamin D levels on efficacy of teriparatide 20 μg/day administered subcutaneously in Japanese patients with osteoporosis. J Bone Miner Metab 31:199–205
    Eriksen EF, Charles P, Melsen F, Mosekilde L, Risteli L, Risteli J (1993) Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. J Bone Miner Res 8:127–132
    Tudor-Locke C, McColl RS (2000) Factors related to variation in premenopausal bone mineral status: a health promotion approach. Osteoporos Int 11:1–24
    Krølner B, Pors NS (1982) Bone mineral content of the lumbar spine in normal and osteoporotic women: cross-sectional and longitudinal studies. Clin Sci (Lond) 62:329–336